Literature DB >> 10399073

Cytomegaloviral control of MHC class I function in the mouse.

H Hengel1, U Reusch, A Gutermann, H Ziegler, S Jonjic, P Lucin, U H Koszinowski.   

Abstract

Cytomegaloviruses (CMVs) represent prototypic viruses of the beta-subgroup of herpesviruses. Murine cytomegalovirus (MCMV) infects mice as its natural host. Among viruses, CMVs have evolved the most extensive genetic repertoire to subvert MHC class I functions. To date three MCMV proteins have been identified which affect MHC I complexes. They are encoded by members of large virus-specific gene families located at either flanking region of the 235 kb MCMV genome. The MHC I subversive genes belong to the early class of genes and code for type I transmembrane glycoproteins. The m152-encoded 37/40 kDa glycoprotein interacts with MHC I transiently and retains class I complexes in the endoplasmic reticulum (ER) Golgi intermediate compartment on its journey to the endolysosome. In contrast, the m06-encoded glycoprotein of 48 kDa complexes tightly with ternary MHC class I molecules in the FR. Due to sorting signals in its cytoplasmic tail, gp48 redirects MHC I to endolysosomal compartments for proteolytic destruction. Likewise, the 34 kDa glycoprotein encoded by m04 binds tightly to MHC class I complexes in the ER but the gp34/MHC I complex reaches the plasma membrane. The CD8+ T-cell-dependent attenuation of a m152 deletion mutant virus proves for the first time that inhibition of antigen presentation is indeed essential for the biological fitness of CMVs in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399073     DOI: 10.1111/j.1600-065x.1999.tb01291.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  42 in total

1.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance.

Authors:  Sofia A Oliveira; Se-Ho Park; Peter Lee; Albert Bendelac; Thomas E Shenk
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus.

Authors:  Diane M LoPiccolo; Marielle C Gold; Daniel G Kavanagh; Markus Wagner; Ulrich H Koszinowski; Ann B Hill
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  MCMV avoidance of recognition and control by NK cells.

Authors:  Ilija Brizić; Tihana Lenac Roviš; Astrid Krmpotić; Stipan Jonjić
Journal:  Semin Immunopathol       Date:  2014-08-21       Impact factor: 9.623

5.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

6.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.

Authors:  Lisa P Daley-Bauer; Grace M Wynn; Edward S Mocarski
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

8.  Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo.

Authors:  Marina Babić; Michal Pyzik; Biljana Zafirova; Maja Mitrović; Višnja Butorac; Lewis L Lanier; Astrid Krmpotić; Silvia M Vidal; Stipan Jonjić
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

9.  Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.

Authors:  Jurica Arapovic; Tihana Lenac; Ronald Antulov; Bojan Polic; Zsolt Ruzsics; Leonidas N Carayannopoulos; Ulrich H Koszinowski; Astrid Krmpotic; Stipan Jonjic
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

Review 10.  Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.

Authors:  Niels A W Lemmermann; Annette Fink; Jürgen Podlech; Stefan Ebert; Vanessa Wilhelmi; Verena Böhm; Rafaela Holtappels; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2012-09-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.